Plerixafor for mobilization of blood stem cells in autologous transplantation: an update.

Item

http://www.wikidata.org/entity/Q38199707

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Plerixafor for mobilization of blood stem cells in autologous transplantation: an update.

@en

type

Item

label

Plerixafor for mobilization of blood stem cells in autologous transplantation: an update.

@en

prefLabel

Plerixafor for mobilization of blood stem cells in autologous transplantation: an update.

@en

P1476

Plerixafor for mobilization of blood stem cells in autologous transplantation: an update.

@en

P2093

Esa Jantunen

http://www.w3.org/2001/XMLSchema#string

P2860

How I treat patients who mobilize hematopoietic stem cells poorly

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event

Hematopoietic SCT in Europe: data and trends in 2011.

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data.

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.

Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.

P304

851-861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2014.902927

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ville Varmavuo

P577

2014-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24673120

http://www.w3.org/2001/XMLSchema#string